Genentech

7 abstracts

Abstract
Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions.
Org: SOMC Cancer Center, Banner University Medical Center, Sanford USD Medical Center,
Abstract
Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
Org: Sylvester Comprehensive Cancer Center, Miami, FL, University of Miami Miller School of Medicine, Miami, FL, American Society of Clinical Oncology, Herbert-Herman Cancer Center, Michigan Cancer Research Consortium,
Abstract
Oncology Financial Advocacy Services Guidelines: Results of a Delphi study.
Org: Association of Community Cancer Centers (ACCC), Rockville, MD, Rhizome, LLC, School of Social Policy & Practice, University of Pennsylvania, AONN+, National Patient Advocate Foundation,
Abstract
Examining molecular testing practices and targeted therapy use in advanced/metastatic non-small cell lung cancer (mNSCLC): A quality improvement initiative across ten community cancer centers.
Org: Sylvester Comprehensive Cancer Center, Miami, FL, University of Miami Miller School of Medicine, Miami, FL, PRIME Education LLC,
Abstract
Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.
Org: US Oncology Research/New York Oncology Hematology, Albany, NY, US Oncology Research/Oncology Associates of Oregon P.C., Eugene, OR, US Oncology Research/Virginia Oncology Associates, Newport News, VA, US Oncology Research/Oncology Hematology Care, Inc., The Woodlands, TX, US Oncology Research/Virginia Cancer Specialists, Fairfax, VA,
Abstract
The impact of 4R Oncology Model on patient self management and satisfaction in lung versus breast cancer.
Org: Center for Business Models on Healthcare, Northwestern University Feinberg School of Medicine, Kaiser Permanente Oakland Medical Center, Division of Research Services, Kaiser Permanente Northern California,